Cellular signalling mechanisms in adaptation to ischemia-induced myocardial damage

Annals of Medicine

Volumn 35, Issue 5, 2003, Pages 300-307

  Valen, Guro ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Apoptosis; Ischemia reperfusion injury; Preconditioning; Signal transduction; Unstable angina

Indexed keywords

ACUTE PHASE PROTEIN; CHEMOKINE; CYTOKINE; DNA FRAGMENT; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; L SELECTIN;

ADAPTATION; APOPTOSIS; CORONARY ARTERY ATHEROSCLEROSIS; GENE ACTIVATION; HEART MUSCLE CELL; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART MUSCLE NECROSIS; HEART PROTECTION; HUMAN; MORBIDITY; MORTALITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; REPERFUSION INJURY; REVIEW; SIGNAL TRANSDUCTION; UNSTABLE ANGINA PECTORIS;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; APOPTOSIS; ARTERIOSCLEROSIS; CELLS, CULTURED; DNA FRAGMENTATION; HUMANS; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MYOCARDIAL ISCHEMIA; NF-KAPPA B; NITRIC OXIDE; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0042889305     PISSN: 07853890     EISSN: None     Source Type: Journal    
DOI: 10.1080/07853890310001348     Document Type: Review

References (65)

1. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986; 74: 1124-36.
2. Guo Y, Wu WJ, Qiu Y, Tang XL, Yang Z, Bolli R. Demonstration of an early and a late phase of ischemic preconditioning in mice. Am J Physiol 1998; 275: H1375-87.
3. Oxman T, Arad M, Klein R, Avazov N, Rabinowitz B. Limb ischemia preconditions the heart against reperfusion tachyarrhythmia. Am J Physiol 1997; 273: H1707-12.
4. Gho BC, Schoemaker RG, van den Doel MA, Duncker DJ, Verdouw PD. Myocardial protection by brief ischemia in noncardiac tissue. Circulation 1996; 94: 2193-200.
5. Takaoka A, Nakae I, Mitsunami K, Yabe T, Morikawa S, Inubushi T, et al. Renal ischemia/reperfusion remotely improves myocardial energy metabolism during myocardial ischemia via adenosine receptors in rabbits: effects of 'remote preconditioning'. J Am Coll Cardiol 1999; 33: 556-64.
6. Tomai F, Crea F, Chiarello L, Gioffre PA. Ischemic preconditioning in humans. Models, mediators, and clinical relevance. Circulation 1999; 100: 559-63.
7. Kloner RA, Speakman MT, Przyklenk K. Ischemic preconditioning: a plea for rationally targeted clinical trials. Cardiovasc Res 2002; 55: 526-33.
8. de Zeeuw S, van den Doel M, Duncker DJ, Verdouw PD. New insights into cardioprotection by ischemic preconditioning and other forms of stress. Ann NY Acad Sci 1999; 874: 178-91.
9. Illes RW, Swoyer KD. Prospective, randomized clinical study of ischemic preconditioning as an adjunct to intermittent blood cardioplegia. Ann Thorac Surg 1998; 65: 752-3.
10. Kaukoranta PK, Lepojarvi MP, Ylitalo KV, Kiviuoma KT, Peuhkurinen KJ. Normothermic retrograde cardioplegia with or without preceding ischemic preconditioning. Ann Thorac Surg 1997; 63: 1264-8.
11. Malkowski MJ, Kramer CM, Parvizi ST, Dianzumba S, Marquez J, Reichek N, et al. Transient ischemia does not limit subsequent regional dysfunction in humans: a transesophageal echocardiographic study during minimally invasive coronary artery bypass surgery. J Am Coll Cardiol 1998; 31: 1035-9.
12. Hirai T, Fujita M, Yamanishi K, Ohno A, Miwa K, Sasayama S. Significance of preinfarction angina for preservation of left ventricular function in acute myocardial infarction. Am Heart J 1993; 124: 19-23.
13. Kloner RA, Shook T, Przyklenk K, Davis VG, Junio L, Matthews RV, et al. Previous angina alters in-hospital outcome in TIMI 4. A clinical correlate to preconditioning? Circulation 1995; 91: 37-47.
14. Bolli R, Manchikalapudi S, Tang X-L, Takano H, Qiu Y, Guo Y, et al. The protective effect of late preconditioning against myocardial stunning in conscious rabbits is mediated by nitric oxide synthase. Circ Res 1997; 81: 1094-107.
15. Takano H, Tang XL, Qiu Y, French BA, Bolli R. Nitric oxide donors induce late preconditioning against myocardial stunning and infarction in conscious rabbits via an antioxidant sensitive mechanism. Circ Res 1998; 83: 73-84.
16. Parrat JR, Vegh A. Coronary vascular endothelium-myocyte interactions in protection of the heart by ischemic preconditioning. J Physiol Pharmacol 1999; 50: 509-24.
17. Cohen MV, Baines CP, Downey JM. Ischemic preconditioning: From adenosine receptor to KATP channel. Ann Rev Physiol 2000; 62: 79-109.
18. Das DK, Engelman RM, Maulik N. Oxygen free radical signalling in ischemic preconditioning. In: Das DK, (ed). Heart in stress. New York: Ann NY Acad Sci; 1999; 874: 49-65.
19. Sato T, Sasaki N, O'Rourke B, Marban E. Adenosine primes the opening of mitochondrial ATP-sensitive potassium channels: a key step in ischemic preconditioning? Circulation 2000; 102: 800-5.
20. de Jong JW, de Jonge R, Keijzer E, Bradamante S. The role of adenosine in preconditioning. Pharmacol Ther 2000; 87: 141-9.
21. ATP channels. Am J Physiol 2001; 280: H1278-85.
22. Pain T, Yang XM, Critz SD, Yue Y, Nakano A, Liu GS, et al. Opening of mitochondrial K(ATP) channels triggers the preconditioned state by generating free radicals. Circ Res 2000; 87: 431-3.
23. Maulik N, Sato M, Price BD, Das DK. An essential role of NFkB in tyrosine kinase signalling of p38 MAP kinase regulation of myocardial adaptation to ischemia. FEBS Lett 1998; 429: 365-9.
24. Xuan Y-T, Tang X-L, Banerjee S, Takano H, Li R C.X., Han H, et al. Nuclear factor-kB plays an essential role in the late phase of ischemic preconditioning in conscious rabbits. Circ Res 1999; 84: 1095-109.
25. Marber MS, Latchman DS, Walker JM, Yellon DM. Cardiac stress protein elevation 24 hours after brief ischaemia or heat stress is associated with resistance to myocardial infarction. Circulation 1993; 88: 1264-72.
26. Dana A, Skarli M, Papakrivopoulou J, Yellon DM. Adenosine A(1) receptor induced delayed preconditioning in rabbits: induction of p38 mitogen-activated protein kinase activation and HSP27 phosphorylation via tyrosine kinase and protein kinase C dependent mechanism. Circ Res 2000; 86: 989-97.
27. Steeves G, Singh N, Singal PK. Ischemic preconditioning and antioxidant defence against reperfusion injury. In: Das DK, ed. Cellular, biochemical, and molecular aspects of reperfusion injury. Ann New York Acad Sci 1994; 723: 116-27.
28. Guo Y, Jones WK, Xuan YT, Tang XL, Bao W, Wu WJ, et al. The late phase of ischemic preconditioning is abrogated by targeted disruption of the inducible NO synthase gene. Proc Natl Acad Sci USA 1999; 96: 11507-12.
29. Shinmura K, Tang XL, Wang Y, Liu SQ, Takano H, Bhatnagar A, et al. Cyclooxygenase-2 mediates the cardioprotective effects of the late phase of ischemic preconditioning in conscious rabbits. Proc Natl Acad Sci USA 2000; 97: 10197-202.
30. Valen G, Yah Z-Q, Hansson GK. Nuclear Factor kappa-B and the heart. J Am Coll Cardiol 2001; 38: 307-14.
31. Lawrence T, Gilroy DW, Colville-Nash PR, Willoughby DA. Possible role for NF-kB in the resolution of inflammation. Nat Med 2001; 7: 1291-7.
32. Morgan EN, Boyle EM, Yun W, Griscavage-Ennis JM, Farr A, Canty TG, et al. An essential role for NFkB in the cardioadaptive response to ischemia. Ann Thorac Surg 1999; 68: 377-82.
33. Zhao T, Chelliah J, Levasseur JE, Kukreja RC. Inducible nitric oxide synthase mediates delayed myocardial protection induced by activation of adenosine A(1) receptors: Evidence from gene-knockout animals. Circulation 2000; 102: 902-7.
34. Zhao TC, Taher MM, Valerie KC, Kukreja RC. P38 triggers late preconditioning elicited by anisomycin in heart. Involvement of NFkB and iNOS. Circ Res 2001; 89: 915-22.
35. Smith RM, Lecour S, Sachs MN. Innate immunity and cardioprotective preconditioning: a putative intrinsic cardioprotective program. Cardiovasc Res 2002; 55: 474-82.
36. Von Albertini M, Palmetshofer A, Kaczmarek E, Koziak K, Stroka D, Grey ST, et al. Extracellular ATP and ADP activate transcription factor NF-kappaB and induce endothelial cell apoptosis. Biochem Biophys Res Commun 1998; 248: 822-9.
37. Nie Z, Mei Y, Ford M, Rybak L, Marcuzzi A, Ren H, et al. Oxidative stress increases adenosine A1 receptor expression by activating nuclear factor kappa B. Mol Pharmacol 1998; 53: 663-9.
38. Li C, Tuanzhu T, Liu L, Browder W, Kao RL. Adenosine prevents activation of transcription factor NF-kB and enhances activator protein-1 binding activity in ischemic rat heart. Surgery 2000; 127: 161-9.
39. Carroll R, Yellon DM. Delayed cardioprotection in a human cardiomyocyte-derived cell line: the role of adenosine, p38MAP kinase and mitochondrial KATP. Basic Res Cardiol 2000; 95: 243-9.
40. Dana A, Jonassen AK, Yamashita N, Yellon DM. Adenosine A(1) receptor activation induces delayed preconditioning in rats mediated by manganese superoxide dismutase. Circulation 2000; 101: 2841-8.
41. Tähepôld P, Starkopf J, Vaage J, Valen G. Hyperoxia elicits preconditioning through a NFkB-dependent mechanism in the rat heart. J Thorac Cardiovasc Surg 2003; 125: 650-60.
42. Zahler S, Kupatt C, Becker BF. Endothelial preconditioning by transient oxidative stress reduces inflammatory responses of cultured endothelial cells to TNF-alpha. FASEB J 2000; 14: 555-64.
43. Hiasa G, Hamada M, Ikeda S, Hiwada K. Ischemic preconditioning and lipopolysaccharide attenuate nuclear factor kappa-B activation and gene expression of inflammatory cytokines in the ischemic-reperfused rat heart. Jpn Circ J 2001; 65: 984-90.
44. Carter DA. Modulation of cellular AP-1 DNA binding activity by heat shock proteins. FEBS Lett 1997; 416: 81-5.
45. Vayssier M, Favatier F, Pinot F, Bachelet M, Polla BS. Tobacco smoke induces coordinate activation of HSF and inhibition of NFkappaB in human monocytes: effects on TNFalpha release. Biochem Biophys Res Commun 1998; 252: 249-56.
46. Maulik N, Goswami S, Galang N, Das DK. Differential regulation of Bcl-2, AP-1, and NFkB on cardiomyocyte apoptosis during myocardial ischemic stress adaption. FEBS Lett 1999; 443: 331-6.
47. Zhu L, Fukuda S, Cordis G, Das DK, Maulik N. Antiapoptotic protein survivin plays a significant role in tubular morphogenesis of human coronary arteriolar endothelial cells by hypoxic preconditioning. FEBS Lett 2001; 508: 369-74.
48. Erl W, Hansson GK, de Martin R, Draude G, Weber KS, Weber C. Nuclear factor-kappa B regulates induction of apoptosis and inhibitor of apoptosis protein-1 expression in vascular smooth muscle cells. Circ Res 1999; 84: 668-77.
49. Liston P, Roy N, Tamai K, Lefebvre C, Baird S, Cherton-Horvat G, et al. Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes. Nature 1996: 379349-53.
50. Mallat Z, Tedgui A. Current perspective on the role of apoptosis in atherothrombotic disease. Circ Res 2001; 88: 998-1003.
51. Bennet MR. Apoptosis of vascular smooth muscle cells in vascular remodelling and atherosclerotic plaque rupture. Cardiovasc Res 1999; 41: 361-8.
52. Kang PM, Izumo S. Apoptosis and heart failure. A critical review of the literature. Circ Res 2000; 86: 1107-13.
53. Joza N, Susin SA, Daugas E, Stanford WL, Cho SK, Li CYJ, et al. Essential role of the mitochondrial apoptosis-inducing factor in programmed cell death. Nature 2001; 410: 549-54.
54. Kruidering M, Evan GI. Caspase 8 in apoptosis: The beginning of 'the end'? Life 2000; 50: 85-90.
55. Feuerstein GZ, Young PR. Apoptosis in cardiac disease: stress- and mitogen activated signalling pathways. Cardiovasc Res 2000; 45: 560-9.
56. Saraste A, Pulkki K. Morphologic and biochemical hallmarks of apoptosis. Cardiovasc Res 2000; 45: 528-37.
57. Elsässer A, Suzuki K, Schaper J. Unresolved issues regarding the role of apoptosis in the pathogenesis of ischemic injury and heart failure. J Mol Cell Cardiol 2000; 32: 711-24.
58. Valen G. The basic biology of apoptosis and its implications for cardiac function and viability. Ann Thorac Surg 2003; 75: S656-60.
59. Liu H, Zhang HY, McPherson BC, Baman T, Roth S, Shao Z, et al. Role of opoid delta receptors, mitochondrial K(ATP) channels, and protein kinase C during cardiocyte apoptosis. J Mol Cell Cardiol 2001; 33: 2007-14.
60. Lin KM, Lin B, Lian IY, Mestril R, Scheffer IE, Dillmann WH. Combined and individual mitochondrial HSP60 and HSP10 expression in cardiac myocytes protects mitochondrial function and prevents apoptotic cell deaths induced by simulated ischemia-reoxygenation. Circulation 2001; 103: 1787-92.
61. Li G, Tokuno S, Tähepôld P, Vaage J, Löwbeer C, Valen G. Ischemic and hyperoxic preconditioning improve myocardial function and reduce infarct size in the severely atherosclerotic mouse heart. Ann Thorac Surg 2001; 71: 1296-303.
62. Mehta JL, Saldeen TGP, Rand K. Interactive role of infection, inflammation and traditional risk factors in atherosclerosis and coronary artery disease. J Am Coll Cardiol 1998; 31: 1217-25.
63. Valen G, Hansson GK, Dumitrescu A, Vaage J. Unstable angina activates myocardial heat shock protein 72, endothelial nitric oxide synthase, and transcription factors NFkB and AP-1. Cardiovasc Res 2000; 47: 49-56.
64. Tokuno S, Hinokiyama K, Tokuno K, Löwbeer C, Valen G. Spontaneous ischemic events in the heart and brain preconditions the hearts of severely arherosclerotic mice. Atheroscler Thromb Vasc Biol 2002; 22: 995-1001.
65. Tokuno S, Chen F, Jiang J, Pernow J, Valen G. Effects of spontaneous or induced brain infarctions on vessel reactivity: The role of iNOS. Life Sciences 2002; 71: 679-92.